Retrospective analysis identified genotype-phenotype correlations and CRIM status in pediatric Pompe disease, suggesting important therapeutic implications.
Pompe disease (PD) is a rare autosomal recessive disorder caused by pathogenic variants in the GAA gene, resulting in deficient lysosomal acid α-glucosidase activity. Clinical manifestations range from classic infantile-onset (IOPD) to late-onset (LOPD) phenotypes. Understanding genotype-phenotype correlations in PD is essential for prognosis and individualized therapy. This retrospective, single-center study included 26 Vietnamese pediatric patients diagnosed with PD. Clinical, biochemical, and genetic data were systematically collected. Genotype-phenotype correlation, CRIM status distribution, and survival outcomes were analyzed. Of 26 patients, 23 had IOPD and 3 had LOPD. CRIM-positive status was identified in 87.0% of IOPD and 33.3% of LOPD patients. The most frequent variants were c.1843G > A and c.1933G > C. Two previously unreported variants (c.2016del, c.1723T > C) were detected. Hypertrophic cardiomyopathy and hypotonia were universal among IOPD cases. Despite ERT administration in 52.9% of patients, overall mortality in the infantile group was 60.8%. Variant pathogenicity correlated with both CRIM status and clinical outcomes. These findings underscore the clinical importance of comprehensive GAA genotyping and CRIM status determination in predicting disease course and guiding therapeutic decisions. Our results further emphasize the need for population-specific variant databases to inform newborn screening and precision treatment initiatives across Southeast Asia.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: